Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06727799 · ClinicalTrials.gov registry record

A Non-Treatment Clinical Evaluation of the ELITA Single Piece Patient Interface for Docking Procedure With the ELITA

A clinical trial of Refractive Error, sponsored by Johnson & Johnson Surgical Vision.

Completed
Registry status
55
Enrollment target
2
Study locations

NCT06727799 is a study of Refractive Error that has completed, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 55 participants, below the 607-participant average among 5 other Refractive Error trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06727799, a study of Refractive Error, has completed, sponsored by Johnson & Johnson Surgical Vision.

COMPLETED
Registry status
55 participants
Enrollment target
2
Study locations

Study Summary

Open label, prospective, randomized, multicenter, measurement only feasibility study to evaluate the docking procedure using the ELITA Single Piece Patient interface in conjunction with the ELITA system

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Docking Assessment / Observation

Study Locations (2)

California

  • Stanford Eye Laser Center - Palo Alto

Utah

  • Hoopes Vision - Draper

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2024-12-06
Est. Completion 2025-03-28

Sponsor

Johnson & Johnson Surgical Vision

22 total trials

What the Registry Record Tells You About NCT06727799

The ClinicalTrials.gov registry entry for NCT06727799 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 607-participant average among 5 other Refractive Error trials with a reported enrollment target (91% lower). The listed sponsor is Johnson & Johnson Surgical Vision, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Refractive Error appearing as the primary indexed condition, and to 1 intervention - of which Docking Assessment / Observation is the first listed.

NCT06727799 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Utah.

Frequently Asked Questions

What is clinical trial NCT06727799 about?

NCT06727799 is a clinical study titled "A Non-Treatment Clinical Evaluation of the ELITA Single Piece Patient Interface for Docking Procedure With the ELITA". Open label, prospective, randomized, multicenter, measurement only feasibility study to evaluate the docking procedure using the ELITA Single Piece Patient interface in conjunction with the ELITA system

What is the current status of trial NCT06727799?

This trial is currently completed. The enrollment target is 55 participants. The study started on 2024-12-06. Estimated completion is 2025-03-28.

What conditions does trial NCT06727799 study?

This clinical trial studies the following conditions: Refractive Error.

What interventions are being tested in trial NCT06727799?

The interventions under investigation include: Docking Assessment / Observation (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06727799?

This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06727799 being conducted?

This trial has 2 study locations across California, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Refractive Error

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.